You can read more about sitagliptin on the NHS website Pregnancy, breastfeeding and fertility while taking sitagliptin Medications include: GLP-1 therapy (glucagon-like peptide-1 receptor agonists) Dulaglutide ( as Trulicity ) Exenatide ( as Bydureon ) Liraglutide ( as Diavic or Victoza for Type 2 diabetes and Saxenda for weight loss) Semaglutide ( as Ozempic for type 2 diabetes and as Wegovy for weight loss) Dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 agonist Tirzepatide as Mounjaro Guidance from the MHRA published in June 2025 states GLP-1 medicines should not be taken by people who are breastfeeding
A review of the conceptualisation and risk factors associated with treatment-resistant depression
Sulforaphane - role in aging and neurodegeneration
This high degree of stability ensures that longitudinal studies can be carried out without the risk of peptide denaturation or loss of potency over time, providing researchers with a reliable medium for high-fidelity data collection
To be on the safe side, Gendreau says it's better to ignore the front of the box and refer to the official Nutritional Facts Panel on the back
The success of medical weight loss depends on how well the patient responds to the medication, as it is possible for patients to experience adverse side effects or be unable to efficiently increase the dosage of the medication safely
